Shah; Unmesh

Patent Applications and Registrations

Patent applications and USPTO patent grants for Shah; Unmesh.The latest application filed is for "substituted tetrahydroisoquinoline compounds useful as gpr120 agonists".

Company Profile

2.14.14

Shah; Unmesh - Neshanic Station NJ
Shah; Unmesh - Watchung NJ
Shah; Unmesh - Green Brook NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted tetrahydroisoquinoline compounds useful as GPR120 agonists Grant 11,161,819 - Adams , et al. November 2, 2	2021-11-02
Substituted Tetrahydroisoquinoline Compounds Useful As Gpr120 Agonists App 20200347020 - Adams; Gregory L. ; et al.	2020-11-05
Substituted Tetrahydroisoquinoline Compounds Useful As Gpr120 Agonists App 20190161448 - Adams; Gregory L. ; et al.	2019-05-30
Substituted spiropiperidinyl compounds useful as GPR120 agonists Grant 9,708,270 - Chelliah , et al. July 18, 2	2017-07-18
HCV NS3 protease inhibitors Grant 9,328,138 - Rudd , et al. May 3, 2	2016-05-03
Substituted Spiropiperidinyl Compounds Useful As Gpr120 Agonists App 20150274672 - Chelliah; Mariappan ; et al.	2015-10-01
Morpholinone compounds as factor IXA inhibitors Grant 8,987,242 - Chackalamannil , et al. March 24, 2	2015-03-24
HCV NS3 protease inhibitors Grant 8,987,195 - Bara , et al. March 24, 2	2015-03-24
Hcv Ns3 Protease Inhibitors App 20140296136 - Rudd; Michael T. ; et al.	2014-10-02
Hcv Ns3 Protease Inhibitors App 20140057836 - BARA; Thomas ; et al.	2014-02-27
Substituted bicyclic piperidinyl- and piperazinyl-sulfonamides useful to inhibit 11.beta.-hydroxysteroid dehydrogenase type-1 Grant 8,604,195 - Shah , et al. December 10, 2	2013-12-10
6-substituted sulfonyl azabicyclo[3.2.1]octanes useful to inhibit 11.beta.-hydroxysteroid dehydrogenase type-I Grant 8,466,149 - Boyle , et al. June 18, 2	2013-06-18
7-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-yl)-1-piperazinyl]ethyl]-2-(- 1-propynyl)-7H-pyrazolo-[4,3-E]-[1,2,4]-triazolo-[1,5-C]-pyrimidin-5-amine Grant 8,389,532 - Boyle , et al. March 5, 2	2013-03-05
Bridged Bicyclic Heterocycle Derivatives And Methods Of Use Thereof App 20120040975 - Neelamkavil; Santhosh Francis ; et al.	2012-02-16
6-SUBSTITUTED SULFONYL AZABICYCLO[3.2.1]OCTANES USEFUL TO INHIBIT 11Beta-HYDROXYSTEROID DEHYDROGENASE TYPE-1 App 20110237559 - Boyle; Craig D. ; et al.	2011-09-29
Morpholinone Compounds As Factor Ixa Inhibitors App 20110135650 - CHACKALAMANNIL; Samuel ; et al.	2011-06-09
SUBSTITUTED BICYCLIC PIPERIDINYL-AND PIPERAZINYL- SULFONAMIDES USEFUL TO INHIBIT 11beta-HYDROXYSTEROID DEHYDROGENASE TYPE-1 App 20110059929 - Shah; Unmesh ; et al.	2011-03-10
7-[2-[4-(6-FLUORO-3-METHYL-1,2-BENZISOXAZOL-5-YL)-1-PIPERAZINYL]ETHYL]-2-(- 1-PROPYNYL)-7H-PYRAZOLO-[4,3-e]-[1,2,4]-TRIAZOLO-[1,5-c]-PYRIMIDIN-5-AMINE App 20090270432 - Boyle; Craig D. ; et al.	2009-10-29
7-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-yl)-1-piperazinyl]ethyl]-2-(- 1-propynyl)-7H-pyrazolo-[4,3-e]-[1,2,4]-triazolo-[1,5-C]-pyrimidin-5-amine Grant 7,572,802 - Boyle , et al. August 11, 2	2009-08-11
2-heteroaryl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists Grant 7,465,740 - Neustadt , et al. December 16, 2	2008-12-16
7-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-YL)-1-piperazinyl]ethyl]-2-(- 1-propynyl)-7H-pyrazolo-[4,3-e]-[1,2,4]-triazolo-[1,5-c]-pyrimidin-5amine App 20070072867 - Boyle; Craig D. ; et al.	2007-03-29
2-Heteroaryl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists App 20070066620 - Neustadt; Bernard R. ; et al.	2007-03-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.